NSF GRANT AIMS TO SPEED GENE THERAPY TOOL TO MARKET


The National Science Foundation (NSF) has awarded Jin Kim Montclare of the NYU Polytechnic School of Engineering a grant to speed commercialization of an engineered protein and lipid mixture that could deliver nucleic acids into a wide range of living cells with great efficiency.

The research holds enormous commercial potential for gene therapy, as it eliminates the necessity to use multiple reagents or spend countless hours optimizing cell culture conditions. Existing transfection reagents—the chemicals that facilitate the delivery of nucleic acids into cells—are effective with only certain types of cells.

(Read more...)